Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Marsh & Mclennan Companies (MRSH) Cash & Current Investments (2016 - 2026)

Marsh & Mclennan Companies filings provide 18 years of Cash & Current Investments readings, the most recent being $11.7 billion for Q1 2026.

  • On a quarterly basis, Cash & Current Investments rose 1.42% to $11.7 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $11.7 billion, a 1.42% increase, with the full-year FY2025 number at $11.5 billion, up 1.75% from a year prior.
  • Cash & Current Investments reached $11.7 billion in Q1 2026 per MRSH's latest filing, up from $11.5 billion in the prior quarter.
  • The five-year high for Cash & Current Investments was $12.0 billion in Q3 2025, with the low at $772.0 million in Q1 2022.
  • A 5-year average of $6.8 billion and a median of $10.7 billion in 2022 define the central range for Cash & Current Investments.
  • Year-over-year, Cash & Current Investments soared 1374.81% in 2023 and then tumbled 85.71% in 2024.
  • Year by year, Cash & Current Investments stood at $10.7 billion in 2022, then plummeted by 68.5% to $3.4 billion in 2023, then skyrocketed by 235.8% to $11.3 billion in 2024, then grew by 1.75% to $11.5 billion in 2025, then grew by 2.36% to $11.7 billion in 2026.
  • Per Business Quant, the three most recent readings for MRSH's Cash & Current Investments are $11.7 billion (Q1 2026), $11.5 billion (Q4 2025), and $12.0 billion (Q3 2025).